You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Global Briefing

Global OTC Healthcare: Resilience to Global Recession

Jul 2009

Price: US$2,000

About this Report

About this Report


What this report includes

  • Up-to-the minute analysis of the latest trends in the industry
  • New product development, forecasts and other themes
  • Unique graphics and illustrated case studies
  • Most recent brand and company news
  • New insight into the size and shape of the market

Why buy this report

  • Clear, concise powerpoint format makes it easy to digest
  • Leading industry opinion keeps you abreast of latest news and trends
  • Forward-looking outlook on a category, market or issue affecting the industry
  • Latest five year forecasts assess how the market is predicted to develop
  • Understand the competitive environment, the leading players and brands

Delivery format

PDF/PPT
Downloadable from MyPages

Table of Contents

Table of Contents

Objectives and Parameters

Definitions

Objectives for Global Briefing

Key Findings

Global Picture

OTC Healthcare Edges Ahead

Steady Growth in Mature Sectors Limits Effects of Downturn

Close Up of Year on Year Growth by Category

Regional Overview

US Still Generates the Bulk of Sales and Global Growth

OTC Healthcare Spending per Capita Top and Bottom Markets

US Shapes Global Performance

Eastern Europe Most Dynamic

Russia Drives Eastern Europe

Russian Market Accelerates Despite Economic Woes

Western Europe Underperforms

Changing Attitudes in Europe

Centralised Switches to Have Long-term Impact

Fragmented Distribution – A Boost or a Bane

Asia-Pacific: The Two Sides of a Continent

Japan’s Experience with the Recession

China Remains Driver for Growth

Traditional Products and VDS Dominate in Asia-Pacific

“Familiar Face” Drives Direct Sales in Both China and Japan

Australasia’s Liberal Approach Drives Sales

MEA Least Developed But Also Least Affected by the Downturn

Sector Analysis

Prevention Products Start to Slow Down

Vitamin D and Gingko Biloba Most Dynamic

Dietary Supplements Offer Most Opportunities for Growth

Moderate Growth in the Child-specific Sector

Best Growth for CCA in the Last Five Years

Reinventing Analgesics

Digestive Remedies’ Growth Slows

Lifestyle Changes Offer Both Opportunities and Threats

The Threat of Private Label

NRT: Slow Growth Despite Smoking Bans

NRT Smoking Cessation Aids Face Uncertain Future

Eye, Ear and Mouth Care Underperform

Switches Broaden Industry Boundaries and Drive Growth

Legislation a Key Driver for Growth

Competitive Environment

Movers and Shakers

M&A Highlights in 2008 and 2009

M&A: Slow 2008 but Turbulent 2009

Shift in Sector Mix for the Top 10

Sales Gain in 2008

Best Performing Brands in 2008

Amway Strength in VDS Pushes it Higher

Private Label: Highest Gains in 2008

Forecasts

What Does 2009 Hold for OTC?

Regional Growth Forecasts Breakdown

Prevention or Treatment?

Strongest Potential in Asia-Pacific

Most Valuable Markets

Looking Ahead: Key Trends Will Continue to Impact

Samples

OTC - Resilience to Global Recession.jpg

my pages

Want to find out more about this report?